{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:22:19Z","timestamp":1788481339381,"version":"build-2803163510"},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2016,9,14]],"date-time":"2016-09-14T00:00:00Z","timestamp":1473811200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Council for Scientific Research, Lebanon"},{"name":"National Reference Centre for Huntingtons disease"},{"name":"National Reference Centre for Huntingtons disease"},{"name":"AP-HP\/CEA interface contract"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0162890","type":"journal-article","created":{"date-parts":[[2016,9,14]],"date-time":"2016-09-14T17:44:54Z","timestamp":1473875094000},"page":"e0162890","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":14,"title":["Insulin-Like Growth Factor-1 but Not Insulin Predicts Cognitive Decline in Huntington\u2019s Disease"],"prefix":"10.1371","volume":"11","author":[{"given":"Linda","family":"Salem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6832-2335","authenticated-orcid":true,"given":"Gaelle","family":"D\u00e9sam\u00e9ricq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia","family":"Youssov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Dolbeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Cleret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Laure","family":"Bourhis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Azulay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Krystkowiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Verny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Morin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Moutereau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"The French Huntington Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Catherine","family":"Bachoud-L\u00e9vi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Maison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,9,14]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1385\/MN:27:2:153","article-title":"Brain Repair and Neuroprotection by Serum Insulin-Like Growth Factor I","volume":"27","author":"E Carro","year":"2003","journal-title":"Mol Neurobiol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.nlm.2011.08.005","article-title":"Brain insulin signaling: a key component of cognitive processes and a potential basis for cognitive impairment in type 2 diabetes","volume":"96","author":"EC McNay","year":"2011","journal-title":"Neurobiol Learn Mem"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/dneu.20778","article-title":"Toward a comprehensive neurobiology of IGF-I","volume":"70","author":"I Torres-Aleman","year":"2010","journal-title":"Dev Neurobiol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. The Huntington\u2019s Disease Collaborative Research Group","volume":"72","year":"1993","journal-title":"Cell"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"e4962","DOI":"10.1371\/journal.pone.0004962","article-title":"Neuroendocrine disturbances in Huntington\u2019s disease","volume":"4","author":"N Saleh","year":"2009","journal-title":"PloS One"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1212\/WNL.0b013e3181e62076","article-title":"High insulinlike growth factor I is associated with cognitive decline in Huntington disease","volume":"75","author":"N Saleh","year":"2010","journal-title":"Neurology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2174\/156720507780362137","article-title":"Insulin resistance and Alzheimer\u2019s disease pathogenesis: potential mechanisms and implications for treatment","volume":"4","author":"S Craft","year":"2007","journal-title":"Curr Alzheimer Res"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1016\/S0140-6736(02)08655-5","article-title":"Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study","volume":"359","author":"MS Sandhu","year":"2002","journal-title":"Lancet Lond Engl"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/mds.870110204","article-title":"Unified Huntington\u2019s Disease Rating Scale: reliability and consistency. Huntington Study Group","volume":"11","year":"1996","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"ref10","article-title":"Stroop Color and Word Test","author":"C Golden","year":"1978"},{"key":"ref11","article-title":"Wechsler Adult Intelligence Scale\u2013Revised Manual","author":"D Wechsler","year":"1981"},{"key":"ref12","first-page":"207","article-title":"Formal and semantic lexical evocation in normal subjects. Performance and dynamics of production as a function of sex, age and educational level","volume":"90","author":"D Cardebat","year":"1990","journal-title":"Acta Neurol Belg"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1468-1331.2009.02798.x","article-title":"Growth hormone and ghrelin secretion are associated with clinical severity in Huntington\u2019s disease","volume":"17","author":"NA Aziz","year":"2010","journal-title":"Eur J Neurol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000262529","article-title":"Role of the growth hormone\/insulin-like growth factor 1 axis in neurogenesis","volume":"17","author":"D Aberg","year":"2010","journal-title":"Endocr Dev"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ghir.2004.11.004","article-title":"The influence of growth hormone (GH) substitution on patient-reported outcomes and cognitive functions in GH-deficient patients: a meta-analysis","volume":"15","author":"LI Arwert","year":"2005","journal-title":"Growth Horm IGF Res Off J Growth Horm Res Soc Int IGF Res Soc"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S1534-5807(02)00188-0","article-title":"The IGF-1\/Akt pathway is neuroprotective in Huntington\u2019s disease and involves Huntingtin phosphorylation by Akt","volume":"2","author":"S Humbert","year":"2002","journal-title":"Dev Cell"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/01.wad.0000213866.86934.7e","article-title":"Insulin resistance syndrome and Alzheimer disease: pathophysiologic mechanisms and therapeutic implications","volume":"20","author":"S Craft","year":"2006","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000289351","article-title":"Fasting plasma insulin, C-peptide and cognitive change in older men without diabetes: results from the Physicians\u2019 Health Study II","volume":"34","author":"OI Okereke","year":"2010","journal-title":"Neuroepidemiology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"792","DOI":"10.2337\/diacare.20.5.792","article-title":"Insulin and Cognitive Function in an Elderly Population: The Rotterdam Study","volume":"20","author":"RP Stolk","year":"1997","journal-title":"Diabetes Care"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1111\/j.1460-9568.2005.03982.x","article-title":"IGF-I neuroprotection in the immature brain after hypoxia-ischemia, involvement of Akt and GSK3beta?","volume":"21","author":"KG Brywe","year":"2005","journal-title":"Eur J Neurosci"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1046\/j.1460-9568.1999.00623.x","article-title":"Neuroprotective actions of peripherally administered insulin-like growth factor I in the injured olivo-cerebellar pathway","volume":"11","author":"AM Fernandez","year":"1999","journal-title":"Eur J Neurosci"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1517\/14728222.11.12.1535","article-title":"Targeting insulin-like growth factor-1 to treat Alzheimer\u2019s disease","volume":"11","author":"I Torres-Aleman","year":"2007","journal-title":"Expert Opin Ther Targets"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1007\/s12035-013-8585-5","article-title":"IGF-1 intranasal administration rescues Huntington\u2019s disease phenotypes in YAC128 mice","volume":"49","author":"C Lopes","year":"2014","journal-title":"Mol Neurobiol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1212\/01.WNL.0000140292.04932.87","article-title":"Hyperinsulinemia and risk of Alzheimer disease","volume":"63","author":"JA Luchsinger","year":"2004","journal-title":"Neurology"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1212\/WNL.0b013e3181eee25f","article-title":"Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama study","volume":"75","author":"T Matsuzaki","year":"2010","journal-title":"Neurology"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1399-0004.1985.tb00185.x","article-title":"Diabetes mellitus in Huntington disease","volume":"27","author":"LA Farrer","year":"1985","journal-title":"Clin Genet"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/S0140-6736(72)91092-6","article-title":"Increased frequency of diabetes mellitus in patients with Huntington\u2019s chorea","volume":"1","author":"S Podolsky","year":"1972","journal-title":"Lancet Lond Engl"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1159\/000054694","article-title":"Improving influence of insulin on cognitive functions in humans","volume":"74","author":"W Kern","year":"2001","journal-title":"Neuroendocrinology"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3233\/JAD-2009-1165","article-title":"Effects of insulin and octreotide on memory and growth hormone in Alzheimer\u2019s disease","volume":"18","author":"GS Watson","year":"2009","journal-title":"J Alzheimers Dis JAD"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jns.2009.09.022","article-title":"Effects of insulinic therapy on cognitive impairment in patients with Alzheimer disease and diabetes mellitus type-2","volume":"288","author":"M Plastino","year":"2010","journal-title":"J Neurol Sci"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ejphar.2004.02.048","article-title":"Modulation of memory by insulin and glucose: neuropsychological observations in Alzheimer\u2019s disease","volume":"490","author":"GS Watson","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1212\/01.WNL.0000265401.62434.36","article-title":"Intranasal insulin improves cognition and modulates beta-amyloid in early AD","volume":"70","author":"MA Reger","year":"2008","journal-title":"Neurology"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.neurobiolaging.2004.11.011","article-title":"Insulin effects on CSF norepinephrine and cognition in Alzheimer\u2019s disease","volume":"27","author":"GS Watson","year":"2006","journal-title":"Neurobiol Aging"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0162890","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T10:40:21Z","timestamp":1718793621000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0162890"}},"subtitle":[],"editor":[{"given":"David","family":"Blum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,9,14]]},"references-count":33,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2016,9,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0162890","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,14]]}}}